Skip to main content

Table 5 Expanded Prostate Cancer Index Composite-26 (EPIC-26)

From: 1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment

EPIC-26

Baseline (Mean ± SD)

Post-Rt (Mean ± SD)

p

Urinary Incontinence

91.4 ± 16

87.1 ± 20.3

0.18

Urinary/ irritative/Obstructive

83 ± 15.2

78.9 ± 21.3

0.25

Bowel

91.4 ± 9.6

91 ± 14.7

0.90

Sexual

43.5 ± 25.7

36.7 ± 22.4

0.12

Hormonal

88.8 ± 12

89.2 ± 14.4

0.84

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us